Annual Working Capital
$617.69 M
+$40.09 M+6.94%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual working capital is $617.69 million, with the most recent change of +$40.09 million (+6.94%) on December 31, 2023.
- During the last 3 years, XENE annual working capital has risen by +$450.69 million (+269.87%).
- XENE annual working capital is now at all-time high.
Performance
XENE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$629.94 M
-$66.86 M-9.60%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly working capital is $629.94 million, with the most recent change of -$66.86 million (-9.60%) on September 30, 2024.
- Over the past year, XENE quarterly working capital has dropped by -$66.86 million (-9.60%).
- XENE quarterly working capital is now -19.35% below its all-time high of $781.07 million, reached on June 30, 2022.
Performance
XENE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
XENE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.9% | -9.6% |
| 3 y3 years | +269.9% | +22.0% |
| 5 y5 years | +427.0% | +22.0% |
XENE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.4% | -19.4% | +24.4% |
| 5 y | 5-year | at high | +508.6% | -19.4% | +520.7% |
| alltime | all time | at high | +1850.6% | -19.4% | +2151.7% |
Xenon Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $629.94 M(-9.6%) |
| Jun 2024 | - | $696.80 M(+1.7%) |
| Mar 2024 | - | $684.98 M(+10.9%) |
| Dec 2023 | $617.69 M(+6.9%) | $617.69 M(+22.0%) |
| Sep 2023 | - | $506.26 M(-2.0%) |
| Jun 2023 | - | $516.46 M(+1.1%) |
| Mar 2023 | - | $510.86 M(-11.6%) |
| Dec 2022 | $577.60 M(+6.0%) | $577.60 M(-8.8%) |
| Sep 2022 | - | $633.64 M(-18.9%) |
| Jun 2022 | - | $781.07 M(+45.3%) |
| Mar 2022 | - | $537.63 M(-1.3%) |
| Dec 2021 | $544.70 M(+226.2%) | $544.70 M(+123.7%) |
| Sep 2021 | - | $243.46 M(-3.3%) |
| Jun 2021 | - | $251.77 M(-7.4%) |
| Mar 2021 | - | $271.77 M(+62.7%) |
| Dec 2020 | $167.00 M(+64.6%) | $167.00 M(-6.1%) |
| Sep 2020 | - | $177.89 M(-4.3%) |
| Jun 2020 | - | $185.96 M(+0.3%) |
| Mar 2020 | - | $185.35 M(+82.6%) |
| Dec 2019 | $101.49 M | $101.49 M(+19.7%) |
| Sep 2019 | - | $84.78 M(-9.8%) |
| Jun 2019 | - | $94.00 M(-11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $105.67 M(-9.8%) |
| Dec 2018 | $117.21 M(+187.7%) | $117.21 M(-6.3%) |
| Sep 2018 | - | $125.08 M(+104.2%) |
| Jun 2018 | - | $61.26 M(+86.3%) |
| Mar 2018 | - | $32.87 M(-19.3%) |
| Dec 2017 | $40.74 M(-34.4%) | $40.74 M(-2.8%) |
| Sep 2017 | - | $41.93 M(-14.2%) |
| Jun 2017 | - | $48.86 M(-12.0%) |
| Mar 2017 | - | $55.55 M(-10.5%) |
| Dec 2016 | $62.09 M(+6.9%) | $62.09 M(-7.8%) |
| Sep 2016 | - | $67.37 M(+33.5%) |
| Jun 2016 | - | $50.46 M(-8.9%) |
| Mar 2016 | - | $55.40 M(-4.6%) |
| Dec 2015 | $58.08 M(-17.8%) | $58.08 M(-4.4%) |
| Sep 2015 | - | $60.78 M(-2.5%) |
| Jun 2015 | - | $62.34 M(-6.7%) |
| Mar 2015 | - | $66.80 M(-5.5%) |
| Dec 2014 | $70.66 M(+123.1%) | $70.66 M(+121.3%) |
| Sep 2014 | - | $31.93 M(+14.1%) |
| Jun 2014 | - | $27.98 M(-11.6%) |
| Dec 2013 | $31.67 M(-23.7%) | $31.67 M |
| Dec 2012 | $41.51 M | - |
FAQ
- What is Xenon Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual working capital year-on-year change?
- What is Xenon Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly working capital year-on-year change?
What is Xenon Pharmaceuticals annual working capital?
The current annual working capital of XENE is $617.69 M
What is the all time high annual working capital for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual working capital is $617.69 M
What is Xenon Pharmaceuticals annual working capital year-on-year change?
Over the past year, XENE annual working capital has changed by +$40.09 M (+6.94%)
What is Xenon Pharmaceuticals quarterly working capital?
The current quarterly working capital of XENE is $629.94 M
What is the all time high quarterly working capital for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly working capital is $781.07 M
What is Xenon Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, XENE quarterly working capital has changed by -$66.86 M (-9.60%)